Biocytogen is a premier partner that provides one-stop solution for drug development, from concept to IND application. With cutting-edge technologies, state-of-art animal facility, and world-class platforms for efficient antibody drug development, Biocytogen offers animal model generation, antibody fully human RenMab mouse model, therapeutic antibody discovery and development, in vivo/in vitro preclinical studies, CMC/CDMO and regulatory affairs support. Biocytogen collaborates with more than 70% of top 50 pharmaceutical and biotech companies worldwide.